BioCentury
ARTICLE | Regulation

AML decision tree

September 7, 2009 7:00 AM UTC

The 2009 National Comprehensive Cancer Network (NCCN) guidelines for treating acute myelogenous leukemia (AML) provide separate guidelines for patients who are at least 60 years old. According to the ...